Integra LifeSciences Holdings Corporation (IART) Stock Analysis
Free AI-powered analysis and research for Integra LifeSciences Holdings Corporation stock
Sector: Healthcare
Full IART report
Integra LifeSciences Holdings Corporation (IART) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze IART Now βπ° Latest Update
Integra LifeSciences Holdings (IART) Could Be 41% Undervalued On Third Quarter Profit Turnaround
Tue, November 3, 2026 at 1:24 AM UTC 2 min read
Integra LifeSciences Holdings (IART) reported a third quarter profit of US$14.85 million, reversing a previous net loss, with sales reaching US$411.18 million. Despite a recent uptick in share price, the stock has seen a significant decline over the past 90 days, down 23.97%, and long-term returns remain weak. Analysts suggest the stock could be 41% undervalued, but caution that high leverage and ongoing operational challenges may impact investor confidence.